| Robert Stephen Pranger, MD | |
|
220 Southbrooke Dr, Waterloo, IA 50702-5802 | |
| (319) 236-7751 | |
| (319) 236-7753 |
| Full Name | Robert Stephen Pranger |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 23 Years |
| Location | 220 Southbrooke Dr, Waterloo, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972582856 | NPI | - | NPPES |
| 1972582856 | Medicaid | IA | |
| P01020603 | Other | IA | RRMEDICARE |
| 272308584-02 | Other | IA | UNITED HEALTHCARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD34769 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cedar Valley Hospice | Waterloo, IA | Hospice |
| Mercyone Waterloo Medical Center | Waterloo, IA | Hospital |
| Allen Hospital | Waterloo, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Fiat Family Medicine | 9739448267 | 3 |
News Archive
An international team of researchers, including Lukas Kenner from the Clinical Department of Pathology at MedUni Vienna, has discovered a specific combination of mutations and new gene fusions, which are heavily implicated in tumour growth in patients with a particularly aggressive subtype of lymphoma (ALCL).
Oncolytics Biotech Inc. today announced that it has been granted its 30th U.S. Patent, # 7,452,723, entitled "Methods for Preventing Reovirus Recognition for the Treatment of Cellular Proliferative Disorders.
While most RNAs work to create, package, and transfer proteins as determined by the cell's immediate needs, miniature pieces of RNA, called microRNAs (miRNAs) regulate gene expression.
Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that it has initiated a Phase 2, randomized, double-blind, placebo-controlled study evaluating SGX942, a first-in-class innate defense regulator, as a treatment for oral mucositis in patients undergoing chemoradiation therapy for head and neck cancer.
› Verified 2 days ago
| Entity Name | Fiat Family Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194238535 PECOS PAC ID: 9739448267 Enrollment ID: O20180109000851 |
News Archive
An international team of researchers, including Lukas Kenner from the Clinical Department of Pathology at MedUni Vienna, has discovered a specific combination of mutations and new gene fusions, which are heavily implicated in tumour growth in patients with a particularly aggressive subtype of lymphoma (ALCL).
Oncolytics Biotech Inc. today announced that it has been granted its 30th U.S. Patent, # 7,452,723, entitled "Methods for Preventing Reovirus Recognition for the Treatment of Cellular Proliferative Disorders.
While most RNAs work to create, package, and transfer proteins as determined by the cell's immediate needs, miniature pieces of RNA, called microRNAs (miRNAs) regulate gene expression.
Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that it has initiated a Phase 2, randomized, double-blind, placebo-controlled study evaluating SGX942, a first-in-class innate defense regulator, as a treatment for oral mucositis in patients undergoing chemoradiation therapy for head and neck cancer.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert Stephen Pranger, MD 220 Southbrooke Dr, Waterloo, IA 50702-5802 Ph: (319) 236-7751 | Robert Stephen Pranger, MD 220 Southbrooke Dr, Waterloo, IA 50702-5802 Ph: (319) 236-7751 |
News Archive
An international team of researchers, including Lukas Kenner from the Clinical Department of Pathology at MedUni Vienna, has discovered a specific combination of mutations and new gene fusions, which are heavily implicated in tumour growth in patients with a particularly aggressive subtype of lymphoma (ALCL).
Oncolytics Biotech Inc. today announced that it has been granted its 30th U.S. Patent, # 7,452,723, entitled "Methods for Preventing Reovirus Recognition for the Treatment of Cellular Proliferative Disorders.
While most RNAs work to create, package, and transfer proteins as determined by the cell's immediate needs, miniature pieces of RNA, called microRNAs (miRNAs) regulate gene expression.
Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that it has initiated a Phase 2, randomized, double-blind, placebo-controlled study evaluating SGX942, a first-in-class innate defense regulator, as a treatment for oral mucositis in patients undergoing chemoradiation therapy for head and neck cancer.
› Verified 2 days ago
Kurtis Alan Lucas, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2055 Kimball Ave Ste 101, Waterloo, IA 50702 Phone: 319-272-2112 Fax: 319-272-2107 | |
Mark J Louviere, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 212 W Dale St, Waterloo, IA 50703 Phone: 319-235-3568 Fax: 319-235-5013 | |
Dr. Robert L Friedman, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2055 Kimball Ave, Suite 101, Waterloo, IA 50702 Phone: 319-272-2112 Fax: 319-272-2107 | |
Manpreet Singh Gill, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2055 Kimball Ave, Suite 101, Waterloo, IA 50702 Phone: 319-272-2112 Fax: 319-272-2107 | |
Sejla Cejvanovic, ARNP Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 905 Franklin St, Waterloo, IA 50703 Phone: 319-874-3000 | |
Emily Rose Pursley, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: Medical Arts Bldg., 2055 Kimball Ave. Suite 101, Waterloo, IA 50702 Phone: 319-272-2112 | |
Brett D Van Kley, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2055 Kimball Ave, Suite 101, Waterloo, IA 50702 Phone: 319-272-2112 Fax: 319-272-2107 |